7 19 | 36 | | | 36 | 2016 | 44% | 70% | | | 15 | | Trastuzumab Bortezomib | lenalidomide | | | | | Ⅶa | β-1b | | 3 2 | | | | Chidamide Conbercept Apatinib | 31 | 22 9 | | | | |